Haozhe Huang

department of medical oncology

H指数:15

被引数:858

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The PTBP1-RORA axis is a central mediator of the cytotoxic T-cell response to multimodal thermal therapy in hepatocellular carcinom

PTBP1-RORA轴是多模态热疗在肝细胞癌中细胞毒性T细胞反应的中央介导者

Cell Communication and Signaling

IF8.9

2026-08-270

GAS6-inhibiting multi-functional nanoparticles for enhanced cancer therapy

用于增强癌症治疗的GAS6-inhibiting多功能纳米颗粒

Journal of Pharmaceutical Analysis

IF8.9

2026-05-120

OAAI

CT-guided radiofrequency ablation and percutaneous cementoplasty in the treatment of bone metastases: a single-center experience

CT引导下射频消融联合经皮骨水泥注射治疗骨转移瘤：一项单中心经验

MED-X

IF0

2026-05-080

MYC-bound enhancer RNAs in cis regulate gene transcription and tumorigenesis

MYC结合增强子RNA以顺式方式调控基因转录和肿瘤发生

Science Advances

IF12.5

2026-04-240

Multimodal tumor thermal therapy enhances antitumor immunity by expanding tumor-reactive CX3CR1+GPR56+ T cells in hepatocellular carcinoma

多模态肿瘤热疗通过扩增肿瘤反应性CX3CR1+GPR56+ T细胞增强肝癌的抗肿瘤免疫

Theranostics

IF13.3

2026-01-010

PRE

Genetic insights into the causal role of metabolic, immune, and microbial factors in migraine

对代谢、免疫和微生物因素在偏头痛中因果作用的遗传学见解

NEUROGENETICS

IF1.2

2025-12-010

PRE

A feasibility study of [18F] FDG PET/CT radiomics in predicting high-risk cytogenetic abnormalities in multiple myeloma

[18F] FDG PET/CT放射组学在预测多发性骨髓瘤高危细胞遗传学异常中的可行性研究

EJNMMI Research

IF3

2025-10-150

Radiofrequency ablation with or without capecitabine maintenance therapy for lung oligometastases from colorectal cancer

射频消融联合或不联合卡培他滨维持治疗结直肠癌肺寡转移

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2025-09-210

PRE

Integrative characterization of MYC RNA-binding function

MYC RNA结合功能整合表征

Cell Genomics

IF9

2025-05-150

Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance

基于gemcitabine的纳米平台靶向SERPINB9/Granzyme B轴以克服化疗-免疫耐药性的理性开发

NATURE COMMUNICATIONS

IF15.7

2025-05-050

YAP/TAZ Inhibitor-Based Drug Delivery System for Selective Tumor Accumulation and Cancer Combination Therapy

BIOMACROMOLECULES

IF5.4

2024-12-070

PRE

Delivery of PARP inhibitors through 2HG-incorporated liposomes for synergistically targeting DNA repair in cancer

CANCER LETTERS

IF10.1

2024-11-010

PRE

Advanced Hierarchical Computational Modeling-Based Rational Development of Platinum (II) Nanocomplex to Improve Lung Cancer Therapy

ADVANCED FUNCTIONAL MATERIALS

IF19

2024-09-270

PRE

Modulating charge separation of Ce -TiO 2 aerogel supported on chitosan derived ordered porous carbonaceous frameworks for promoting CO 2 photoreduction activity

CERAMICS INTERNATIONAL

IF5.6

2024-09-011

PRE

OIP5-AS1 enhances the malignant characteristics and resistance to chemotherapy of pancreatic cancer cells by targeting miR-30d-5p/ MARCH8

HELIYON

IF3.6

2024-07-011

OAAI

The biological function of Serpinb9 and Serpinb9-based therapy

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-06-202

OAAI

Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer

NATURE COMMUNICATIONS

IF15.7

2024-04-122

OAAI

Habitat-based radiomics analysis for evaluating immediate response in colorectal cancer lung metastases treated by radiofrequency ablation

基于生境的放射组学分析评估射频消融治疗结直肠癌肺转移的即时反应

CANCER IMAGING

IF3.5

2024-03-267

OAAI

In Situ Formation of Fibronectin-Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy

ADVANCED SCIENCE

IF14.1

2024-03-142

Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy

NATURE COMMUNICATIONS

IF15.7

2024-01-0413

OAAI

Haozhe Huang

个人简介

教育背景

工作经历

荣誉奖项

研究方向